Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep784 | Pituitary: clinical | ECE2015

Recurrence of GH-secreting pituitary adenomas during puberty in children with germline AIP mutations: a clinical challenge

Filipponi Silvia , Esposito Vincenzo , Daly Adrian F , Beckers Albert , Jaffrain-Rea Marie-Lise

Germline AIP mutations (AIPmut) predispose to young onset somatotroph pituitary adenomas (GHPA) and gigantism. AIPmut GHPA are often aggressive and resistant to pharmacological treatment, which may be especially challenging in the paediatric setting. We report our experience with two young Italian AIPmut male patients with incipient gigantism due to childhood pituitary macroadenomas, who both experienced recurrent ...

ea0037ep862 | Thyroid cancer | ECE2015

Anaplastic thyroid carcinoma: The failure of conventional therapy but the real promise of targeted therapy

Lennon Paul , Deady Sandra , Healy Marie-Louise , Kinsella John , Timon Conrad , O'Neill James Paul

Introduction: Anaplastic thyroid cancer is a devastating disease with median survival between 1.2 and 10 months. The disease accounts for as little as 0.9–1.6% of total thyroid cancer cases, but may account for up to half of all thyroid cancer mortality. The aim of our study is to evaluate the prognostic factors and outcomes of patients diagnosed with anaplastic thyroid cancer in Ireland and review emerging treatments for this disease.Methods and de...

ea0037ep883 | Thyroid cancer | ECE2015

Aggressive medullary thyroid cancer in a homogenous population

Lennon Paul , Deedy Sandra , Green Andrew , Kinsella John , Timon Conrad , O'Neill James Paul , Healy Marie-Louise

Introduction: Medullary thyroid cancer arises from the calcitonin-secreting parafollicular C cells and consists of a spectrum of disease that ranges from extremely indolent tumours, where patients may survive for many years with a large tumor burden, to aggressive types associated with a high mortality rate. The objective of our study is to evaluate the prognostic factors and outcomes of patients diagnosed with medullary thyroid cancer in a homogenous population, and to examin...

ea0037ep910 | Thyroid cancer | ECE2015

Thyroid cancer in Ireland: a 10-year review of the National Cancer Registry

Lennon Paul , Deedy Sandra , Healy Marie-Louise , Kinsella John , Timon Conrad , O'Neill James Paul

Introduction: The increased incidence of thyroid cancer is driven mainly by a large increase in papillary thyroid cancer (PTC). The number of patients that succumb to the disease has remained stable. The aim of our study is to analyze the incidence and mortality of thyroid cancer in Ireland.Methods and design: A retrospective analysis of the National Cancer Registry was undertaken, between 1st of January 1998 and the 31st December 2007. The Kaplan–M...

ea0037ep1126 | Endocrine tumours | ECE2015

Oestrogen metabolism by steroid sulphatase and 17β-hydroxysteroid dehydrogenases promotes colorectal cancer proliferation via the G-protein coupled oestrogen receptor

Gilligan Lorna , Rahman Habibur , Hewitt Anne-Marie , Taylor Angela , Morton Dion , Foster Paul

Colorectal cancer (CRC) is the third most common cancer worldwide with incidence expected to rise. Although not traditionally viewed as a hormonal cancer, evidence suggests peripheral synthesis of active oestrogens worsens prognosis. Oestrogen metabolising enzymes include steroid sulphatase (STS), which desulphates oestrogens into their active forms, and 17β-hydroxysteroid dehydrogenases (17βHSD), which are estrogen oxidoreductase enzymes. We have previously shown ST...

ea0035oc11.3 | Diabetes and Obesity 2 | ECE2014

Improvement or stabilization of retinopathy and visual acuity after islet transplantation: a 5-year prospective study

Vantyghem Marie-Christine , Quintin Delphine , Labalette Pierre , Kerr-Conte Julie , Pattou Francois

This study describes the evolution of retinopathy 5 years after islet transplantation (IT) with the Edmonton protocol in type 1 diabetic patients. Before IT and then yearly for 5 years, 21 patients (13 islet-alone (ITA), 8 islet-after-kidney (IAK)) underwent monitoring of laboratory parameters, continuous 24 h mean blood pressure (24h BP) and 72 h glucose (CGM), as well as complete ophthalmologic examination. Ten of the 21 patients (48%) were insulin-independent 5 years post-I...

ea0035p148 | Calcium and Vitamin D metabolism | ECE2014

Paternal isodisomy is a frequent cause of pseudohypoparathyroidism 1-b

Colson Cindy , Richard Nicolas , Decamp Mathieu , Abeguile Genevieve , Gruchy Nicolas , Kottler Marie-Laure

Patients affected by pseudohypoparathyroidism type 1b (PHP-1b) develop resistance to PTH leading to hypocalcemia and hyperphosphoremia, which is often associated with resistance to TSH. PHP-Ib is associated with methylation changes at one or several differentially methylated regions (DMRs) within the GNAS complex locus, located at 20q13.2–13.3. This locus gives rise to several different transcripts (NESP55, XL, A/B), with varying patterns of expression depending on the pa...

ea0035p509 | Endocrine disruptors | ECE2014

Estrogen and bisphenol A affect enamel formation by different signaling pathways

Jedeon Katia , Loiodice Sophia , Marciano Clemence , Lavier Marie-Chantal Canivenc , Berdal Ariane , Babajko Sylvie

Bisphenol A (BPA) is a widespread endocrine disrupting chemical strongly suspected to have adverse health effects. Numerous tissues and cells are affected by BPA, and we showed recently that BPA targets include ameloblasts and enamel. We therefore investigated the effects of BPA on ameloblasts and the possible involvement of the estrogen signaling pathway. Rats were exposed daily to low-dose BPA from the conception to 30 days after birth (30 D). Seventy-five percent of 30 D ra...

ea0034p8 | Bone | SFEBES2014

Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice

Pereira Marie , Jeyabalan Jeshmi , Jorgensen Camilla Sofie , Cleasby Mark , Hopkinson Mark , Chenu Chantal

The increased incidence of type 2 diabetes mellitus (T2DM) among the aged is associated with an impaired skeletal structure and a higher prevalence for bone fractures. Besides, anti-diabetic therapies can also negatively affect bone mass. In this study, we tested the skeletal effects of chronic administration of two glucagon-like peptide receptor (GLP-1R) agonists and examined the expression of GLP-1R in bone tissue and cells. Twelve week-old female C57Bl/6N mice were ovariect...

ea0034p137 | Clinical practice/governance and case reports | SFEBES2014

Adrenal incidentalomas, a district hospital perspective

Mtemererwa Brian , Bray Anne de , O'neill Anne-Marie , Webster Alice , Alazzani Halimah , Sada Priyo , Raskauskiene Diana

An incidentaloma is a mass lesion found by chance on imaging for a reason unrelated to the site of the lesion. Adrenal incidentalomas, as a result of advances in imaging technology, have an increased incidence, especially in the aging population. An endocrine referral is advised to determine if the lesion is functional, to exclude malignancy and offer on going appropriate follow-up.Aim: To assess the incidence and audit the management of adrenal incident...